Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × cabozantinib × Clear all

Prostatic Neoplasms

NCT04446117 2025-12-18

CONTACT-02

Phase 3 Active not recruiting

575 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT00940225 2024-04-25

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Phase 2 Completed

730 enrolled 25 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT01522443 2018-05-23

COMET-2

Phase 3 Terminated

119 enrolled 21 charts

Genitourinary

Pain, Prostatic Neoplasms

NCT01605227 2018-03-14

COMET-1

Phase 3 Completed

1,028 enrolled 18 charts

Genitourinary

Pain, Prostatic Neoplasms

Clinical Trials

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

CONTACT-02

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

COMET-2

COMET-1